NCT03957265

Prospective Observational Study of SynCone® Concept

Name: Clinical Trial NCT03957265
Creator: Marcio Zaffalon Casati
Keywords: Jaw, Edentulous, Tapered abutment connection, Phase 1, procedure, clinical trial, Brazil

Prospective Observational Study of SynCone® Concept: Patient-related Outcomes, Clinical, Radiographic, Immunoinflammatory Mediators and Microbiological Analysis

Marcio Zaffalon Casati·Phase 1·ClinicalTrials.gov·procedureRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Jaw, Edentulous
Drug/Device/Intervention: Tapered abutment connection
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Marcio Zaffalon Casati
Funder: Paulista University
Location: São Paulo, Brazil

Timeline & enrollment

Phase: Phase 1
Start date: Mar 03, 2021
End date: Mar 17, 2022
Enrollment: 15 participants

Primary outcome

Modified Gingival Index

Summary

The aim of this prospective observational study will be to evaluate patient-related outcomes, clinical, microbiological and peri-implant immunoinflammatory mediators in completely edentulous patients rehabilitated with delayed loaded overdentures prostheses. The investigators hypothetize that this system could restore edentulous patients with healthier mucosal concerning clinical, microbiological and immunoinflammatory parameters, besides to promote improvement in patient satisfaction and quality of life.

ICD-10 classifications

Dislocation of jawMottled teethDisorder of gingiva and edentulous alveolar ridge, unspecifiedOther disorders of gingiva and edentulous alveolar ridgeOther specified disorders of gingiva and edentulous alveolar ridge

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT03957265
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT03957265 through Pure Global AI's free database. This Phase 1 trial is sponsored by Marcio Zaffalon Casati and is currently Recruiting. The study focuses on Jaw, Edentulous. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.